Related references
Note: Only part of the references are listed.Frequency of Intravitreal Anti-VEGF Injections and Risk of Death A Systematic Review with Meta-analysis
Michele Reibaldi et al.
OPHTHALMOLOGY RETINA (2022)
Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice
Maya H. Maloney et al.
OPHTHALMOLOGY (2021)
Cardiovascular Adverse Events With Intravitreal Anti-Vascular Endothelial Growth Factor Drugs A Systematic Review and Meta-analysis of Randomized Clinical Trials
Nadege Ngo Ntjam et al.
JAMA OPHTHALMOLOGY (2021)
Interactions between ocular and systemic disease using national register-based data in the Danish Excellence Centre in Ophthalmic Epidemiology (DECODE-EYE): study perspective
Jakob Grauslund et al.
ACTA OPHTHALMOLOGICA (2020)
The Validity of Intracerebral Hemorrhage Diagnoses in the Danish Patient Registry and the Danish Stroke Registry
Stine Munk Hald et al.
CLINICAL EPIDEMIOLOGY (2020)
Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
Laura Garcia-Quintanilla et al.
PHARMACEUTICS (2019)
Risk of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice
Maya H. Maloney et al.
OPHTHALMOLOGY (2019)
Overview of Systematic Reviews and Meta-analyses on Systemic Adverse Events Associated With Intravitreal Anti-Vascular Endothelial Growth Factor Medication Use
Marie Thulliez et al.
JAMA OPHTHALMOLOGY (2018)
Validity of Peripheral Arterial Disease Diagnoses in the Danish National Patient Registry
A. N. Lasota et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2017)
SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
Robert L. Avery et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2017)
Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration Findings from a Cochrane Systematic Review
Sharon D. Solomon et al.
OPHTHALMOLOGY (2016)
Catalog of 199 register-based definitions of chronic conditions
Michael F. Hvidberg et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2016)
Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study
Jens Sundboll et al.
BMJ OPEN (2016)
Systemic Safety of Prolonged Monthly Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema A Systematic Review and Meta-analysis
Robert L. Avery et al.
JAMA OPHTHALMOLOGY (2016)
The Danish National Patient Registry: a review of content, data quality, and research potential
Morten Schmidt et al.
CLINICAL EPIDEMIOLOGY (2015)
The Danish Civil Registration System as a tool in epidemiology
Morten Schmidt et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2014)
Cardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies Systematic Review and Meta-analysis
Marie Thulliez et al.
JAMA OPHTHALMOLOGY (2014)
Ranibizumab for Diabetic Macular Edema Results from 2 Phase III Randomized Trials: RISE and RIDE
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2012)
CEREBROVASCULAR ACCIDENTS IN PATIENTS TREATED FOR CHOROIDAL NEOVASCULARIZATION WITH RANIBIZUMAB IN RANDOMIZED CONTROLLED TRIALS
Neil M. Bressler et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)
Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
Hude Quan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Risks of Mortality, Myocardial Infarction, Bleeding, and Stroke Associated With Therapies for Age-Related Macular Degeneration
Lesley H. Curtis et al.
ARCHIVES OF OPHTHALMOLOGY (2010)
Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis
Sanjaykumar Hapani et al.
ONCOLOGY (2010)
Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion Six-Month Primary End Point Results of a Phase III Study
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2010)
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
David M. Brown et al.
OPHTHALMOLOGY (2010)
Adverse effects of anticancer agents that target the VEGF pathway
Helen X. Chen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for macular edema from central retinal vein occlusion
PJ Rosenfeld et al.
OPHTHALMIC SURGERY LASERS & IMAGING (2005)
Share Paper
